AH-7921 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "AH-7921" in English language version.

refsWebsite

Global rank English rank

16nih.gov

4^th place

10doi.org

2^nd place

3web.archive.org

1^st place

2usdoj.gov

2,755^th place

1,753^rd place

1espacenet.com

800^th place

676^th place

1csp.edu

low place

1semanticscholar.org

11^th place

8^th place

1racingpost.com

3,602^nd place

2,806^th place

1tga.gov.au

3,984^th place

2,622^nd place

1legislation.gov.au

6,658^th place

4,027^th place

1nevo.co.il

7,200^th place

low place

1legislation.gov.uk

809^th place

536^th place

1anvisa.gov.br

low place

1sfda.gov.cn

low place

1mzcr.cz

low place

1gazette.gc.ca

low place

anvisa.gov.br

portal.anvisa.gov.br

"Resolução da Diretoria Colegiada - RDC nº 87 de 28/06/2016" [Resolution of the Board of Directors - RDC nº 87 of 28/06/2016] (in Portuguese).

csp.edu

online.csp.edu

Krasowski MD, Brown J, eds. (10 January 2017). "The New Wave of Designer Drugs". Forensic Scholars Today. Concordia University, St. Paul Online. Retrieved 2017-12-03.

doi.org

Katselou M, Papoutsis I, Nikolaou P, Spiliopoulou C, Athanaselis S (2015). "AH-7921: the list of new psychoactive opioids is expanded". Forensic Toxicology. 33 (2): 195–201. doi:10.1007/s11419-015-0271-z. PMC 4525185. PMID 26257832.
Brittain RT, Kellett DN, Neat ML, Stables R (September 1973). "Proceedings: Anti-nociceptive effects in N-substituted cyclohexylmethylbenzamides". British Journal of Pharmacology. 49 (1): 158P–159P. doi:10.1111/j.1476-5381.1973.tb08279.x. PMC 1776456. PMID 4207044.
Hayes AG, Tyers MB (July 1983). "Determination of receptors that mediate opiate side effects in the mouse". British Journal of Pharmacology. 79 (3): 731–736. doi:10.1111/j.1476-5381.1983.tb10011.x. PMC 2044905. PMID 6317119.
Harper NJ, Veitch GB, Wibberley DG (November 1974). "1-(3,4-Dichlorobenzamidomethyl)cyclohexyldimethylamine and related compounds as potential analgesics". Journal of Medicinal Chemistry. 17 (11): 1188–1193. doi:10.1021/jm00257a012. PMID 4416926.
Zawilska JB (2017-06-30). "An Expanding World of Novel Psychoactive Substances: Opioids". Frontiers in Psychiatry. 8: 110. doi:10.3389/fpsyt.2017.00110. PMC 5492455. PMID 28713291.
Wohlfarth A, Scheidweiler KB, Pang S, Zhu M, Castaneto M, Kronstrand R, Huestis MA (August 2016). "Metabolic characterization of AH-7921, a synthetic opioid designer drug: in vitro metabolic stability assessment and metabolite identification, evaluation of in silico prediction, and in vivo confirmation". Drug Testing and Analysis. 8 (8): 779–791. doi:10.1002/dta.1856. PMC 4562414. PMID 26331297.
Uchiyama N, Matsuda S, Kawamura M, Kikura-Hanajiri R, Goda Y (July 2013). "Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products". Forensic Toxicology. 31 (2): 223–240. doi:10.1007/s11419-013-0182-9. S2CID 1279637.
Vorce SP, Knittel JL, Holler JM, Magluilo J, Levine B, Berran P, Bosy TZ (May 2014). "A fatality involving AH-7921". Journal of Analytical Toxicology. 38 (4): 226–230. doi:10.1093/jat/bku011. PMID 24523294.
Fels H, Krueger J, Sachs H, Musshoff F, Graw M, Roider G, Stoever A (August 2017). "Two fatalities associated with synthetic opioids: AH-7921 and MT-45". Forensic Science International. 277: e30–e35. doi:10.1016/j.forsciint.2017.04.003. PMID 28506719.
Rambaran KA, Amin ZM, Fleming SW, Chacko L, Alzghari SK (July 2018). "AH-7921: A review of previously published reports". Proceedings. 31 (3): 303–306. doi:10.1080/08998280.2018.1465320. PMC 5997081. PMID 29904293.

espacenet.com

worldwide.espacenet.com

US patent 3975443, Harper N, Veitch G, "1-(3,4-Dichlorobenzamidomethyl)-cyclohexyldimethylamine", issued 1976-08-17, assigned to Allen & Hanburys

gazette.gc.ca

"Regulations Amending the Food and Drug Regulations (Parts G and J — Lefetamine, AH-7921, MT-45 and W-18)". The Government of Canada. June 2016.

legislation.gov.au

"Poisons Standard Amendment No. 2 of 2014". Federal Register of Legislation. Commonwealth of Australia. 19 May 2014.

legislation.gov.uk

"The Misuse of Drugs Act 1971 (Amendment) (No. 2) Order 2014". Legislation.gov.uk.

mzcr.cz

"Látky, o které byl doplněn seznam č. 4 psychotropních látek (příloha č. 4 k nařízení vlády č. 463/2013 Sb.)" [Substances added to list No. 4 of psychotropic substances (Annex No. 4 to Government Regulation No. 463/2013 Coll.)] (PDF) (in Czech). Ministerstvo zdravotnictví. Archived from the original (PDF) on 2016-03-09. Retrieved 2016-02-06.

nevo.co.il

"פקודת הסמים המסוכנים נוסח חדש, תשל"ג -1973" [The Dangerous Drugs Ordinance, new version, 5733] (in Hebrew).

nih.gov

pubmed.ncbi.nlm.nih.gov

Katselou M, Papoutsis I, Nikolaou P, Spiliopoulou C, Athanaselis S (2015). "AH-7921: the list of new psychoactive opioids is expanded". Forensic Toxicology. 33 (2): 195–201. doi:10.1007/s11419-015-0271-z. PMC 4525185. PMID 26257832.
Brittain RT, Kellett DN, Neat ML, Stables R (September 1973). "Proceedings: Anti-nociceptive effects in N-substituted cyclohexylmethylbenzamides". British Journal of Pharmacology. 49 (1): 158P–159P. doi:10.1111/j.1476-5381.1973.tb08279.x. PMC 1776456. PMID 4207044.
Hayes AG, Tyers MB (July 1983). "Determination of receptors that mediate opiate side effects in the mouse". British Journal of Pharmacology. 79 (3): 731–736. doi:10.1111/j.1476-5381.1983.tb10011.x. PMC 2044905. PMID 6317119.
Harper NJ, Veitch GB, Wibberley DG (November 1974). "1-(3,4-Dichlorobenzamidomethyl)cyclohexyldimethylamine and related compounds as potential analgesics". Journal of Medicinal Chemistry. 17 (11): 1188–1193. doi:10.1021/jm00257a012. PMID 4416926.
Zawilska JB (2017-06-30). "An Expanding World of Novel Psychoactive Substances: Opioids". Frontiers in Psychiatry. 8: 110. doi:10.3389/fpsyt.2017.00110. PMC 5492455. PMID 28713291.
Wohlfarth A, Scheidweiler KB, Pang S, Zhu M, Castaneto M, Kronstrand R, Huestis MA (August 2016). "Metabolic characterization of AH-7921, a synthetic opioid designer drug: in vitro metabolic stability assessment and metabolite identification, evaluation of in silico prediction, and in vivo confirmation". Drug Testing and Analysis. 8 (8): 779–791. doi:10.1002/dta.1856. PMC 4562414. PMID 26331297.
Vorce SP, Knittel JL, Holler JM, Magluilo J, Levine B, Berran P, Bosy TZ (May 2014). "A fatality involving AH-7921". Journal of Analytical Toxicology. 38 (4): 226–230. doi:10.1093/jat/bku011. PMID 24523294.
Fels H, Krueger J, Sachs H, Musshoff F, Graw M, Roider G, Stoever A (August 2017). "Two fatalities associated with synthetic opioids: AH-7921 and MT-45". Forensic Science International. 277: e30–e35. doi:10.1016/j.forsciint.2017.04.003. PMID 28506719.
Rambaran KA, Amin ZM, Fleming SW, Chacko L, Alzghari SK (July 2018). "AH-7921: A review of previously published reports". Proceedings. 31 (3): 303–306. doi:10.1080/08998280.2018.1465320. PMC 5997081. PMID 29904293.

ncbi.nlm.nih.gov

Katselou M, Papoutsis I, Nikolaou P, Spiliopoulou C, Athanaselis S (2015). "AH-7921: the list of new psychoactive opioids is expanded". Forensic Toxicology. 33 (2): 195–201. doi:10.1007/s11419-015-0271-z. PMC 4525185. PMID 26257832.
Brittain RT, Kellett DN, Neat ML, Stables R (September 1973). "Proceedings: Anti-nociceptive effects in N-substituted cyclohexylmethylbenzamides". British Journal of Pharmacology. 49 (1): 158P–159P. doi:10.1111/j.1476-5381.1973.tb08279.x. PMC 1776456. PMID 4207044.
Hayes AG, Tyers MB (July 1983). "Determination of receptors that mediate opiate side effects in the mouse". British Journal of Pharmacology. 79 (3): 731–736. doi:10.1111/j.1476-5381.1983.tb10011.x. PMC 2044905. PMID 6317119.
Zawilska JB (2017-06-30). "An Expanding World of Novel Psychoactive Substances: Opioids". Frontiers in Psychiatry. 8: 110. doi:10.3389/fpsyt.2017.00110. PMC 5492455. PMID 28713291.
Wohlfarth A, Scheidweiler KB, Pang S, Zhu M, Castaneto M, Kronstrand R, Huestis MA (August 2016). "Metabolic characterization of AH-7921, a synthetic opioid designer drug: in vitro metabolic stability assessment and metabolite identification, evaluation of in silico prediction, and in vivo confirmation". Drug Testing and Analysis. 8 (8): 779–791. doi:10.1002/dta.1856. PMC 4562414. PMID 26331297.
Rambaran KA, Amin ZM, Fleming SW, Chacko L, Alzghari SK (July 2018). "AH-7921: A review of previously published reports". Proceedings. 31 (3): 303–306. doi:10.1080/08998280.2018.1465320. PMC 5997081. PMID 29904293.

pubchem.ncbi.nlm.nih.gov

"AH-7921: 3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide". PubChem. U.S. National Library of Medicine. Retrieved 2017-12-06.

racingpost.com

Godfrey N (12 November 2015). "Two horses test positive for designer drug". Racing Post. Archived from the original on 17 November 2015. Retrieved 29 April 2016.

semanticscholar.org

api.semanticscholar.org

Uchiyama N, Matsuda S, Kawamura M, Kikura-Hanajiri R, Goda Y (July 2013). "Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products". Forensic Toxicology. 31 (2): 223–240. doi:10.1007/s11419-013-0182-9. S2CID 1279637.

sfda.gov.cn

"关于印发《非药用类麻醉药品和精神药品列管办法》的通知" [Notice on Printing and Distributing the "Measures for the Scheduling of Non-Pharmaceutical Narcotic Drugs and Psychotropic Substances"] (in Chinese). China Food and Drug Administration. 27 September 2015. Archived from the original on 1 October 2015. Retrieved 1 October 2015.

tga.gov.au

"Final decisions and reasons for decisions by delegates of the Secretary to the Department of Health" (PDF). Therapeutic Goods Administration (TGA). Commonwealth of Australia. May 2014.

usdoj.gov

deadiversion.usdoj.gov

"2016 - Final Order: Placement of AH-7921 Into Schedule I". www.deadiversion.usdoj.gov. Retrieved 2017-12-03.
"Schedules of Controlled Substances: Placement of AH-7921 Into Schedule I". Drug Enforcement Administration. U.S. Department of Justic. 14 April 2016.

web.archive.org

Godfrey N (12 November 2015). "Two horses test positive for designer drug". Racing Post. Archived from the original on 17 November 2015. Retrieved 29 April 2016.
"关于印发《非药用类麻醉药品和精神药品列管办法》的通知" [Notice on Printing and Distributing the "Measures for the Scheduling of Non-Pharmaceutical Narcotic Drugs and Psychotropic Substances"] (in Chinese). China Food and Drug Administration. 27 September 2015. Archived from the original on 1 October 2015. Retrieved 1 October 2015.
"Látky, o které byl doplněn seznam č. 4 psychotropních látek (příloha č. 4 k nařízení vlády č. 463/2013 Sb.)" [Substances added to list No. 4 of psychotropic substances (Annex No. 4 to Government Regulation No. 463/2013 Coll.)] (PDF) (in Czech). Ministerstvo zdravotnictví. Archived from the original (PDF) on 2016-03-09. Retrieved 2016-02-06.